Information Notice No. 89-85: EPA's Interim Final Rule on Medical Waste Tracking and Management
UNITED STATES
NUCLEAR REGULATORY COMMISSION
OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS
WASHINGTON, D.C. 20555
December 15, 1989
Information Notice No. 89-85: EPA'S INTERIM FINAL RULE ON MEDICAL WASTE
TRACKING AND MANAGEMENT
Addressees:
All medical, academic, industrial, waste broker, and waste disposal site
licensees.
Purpose:
This information notice is provided to inform licensees that the
Environmental Protection Agency (EPA) has promulgated an interim final rule
(40 CFR 259) on medical waste tracking and management under a mandate from
the Medical Waste Tracking Act of 1988. As of June 6, 1989, EPA has
determined that the regulation applies to the medical wastes generated in
five States (known as "Covered States"). These "Covered States" are:
Connecticut, New Jersey, New York, the Commonwealth of Puerto Rico, and
Rhode Island. This notice also identifies and clarifies areas of overlap
between Nuclear Regulatory Commission (NRC) and EPA requirements. Licensees
may wish to review this information for applicability to their programs and
consider actions, as appropriate, as may be required by rule. However,
suggestions contained in this information notice do not constitute NRC
requirements; therefore, no specification or written response is required by
NRC. In addition no specific written response is required by EPA.
Description of Circumstances:
On March 24, 1989, an interim final rule on medical waste tracking and
management under the authority of the Medical Waste Tracking Act of 1988 was
published in the Federal Register, Vol. 54, No. 56, pp. 12326 - 12395. On
June 6, 1989, a supplementary Federal Register Notice, Vol. 54, No. 107, pp.
24310 - 24311, identified the participating States, identified the effective
dates of the new rule, and extended the public comment period. On August
24, 1989, a Federal Register Notice , Vol. 54, No. 153, pp. 35189 - 35191,
removed Louisiana and the District of Columbia from the demonstration
program leaving the States of New York, New Jersey, Connecticut, and Rhode
Island, and the Commonwealth of Puerto Rico as participants in the program.
NRC Part 35 licensees constitute one category of medical institutions
covered by the new EPA rule. Since radioactive materials are sometimes
associated with medical wastes, NRC licensees may be affected by that rule.
Discussion:
The Medical Waste Tracking Act of 1988 requires the EPA to promulgate
regulations on the management of medical wastes by establishing a two-year
demonstration
8912110017
.
IN 89-85
December 15, 1989
Page 2 of 4
program to track medical waste. On March 24, 1989, EPA published "Standards
for the Tracking and Management of Medical Waste; Interim Final Rule and
Request for Comments" in the Federal Register (54 FR 12326). In general,
this EPA rule established criteria and procedures for State participation in
the demonstration program, EPA's definition of "medical wastes" for use
under the Act, and the regulations and standards to be used in the
demonstration program.
The EPA regulation defines the regulated medical wastes applicable to the
demonstration program, it establishes a waste tracking system, and sets out
segregation, packaging, storage, labeling, and marking requirements.
The EPA regulation defines "medical wastes" as "any solid waste which is
generated in the diagnosis, treatment (e.g., provision of medical services),
or immunization of human beings or animals, in research pertaining thereto,
or in the production or testing of biologicals. The term does not include
261.4(b)(1) of this chapter." The
regulation also defines the "regulated medical waste" subject to the new
waste tracking requirements. These "regulated medical wastes" include
cultures and stocks, pathological wastes, human blood and blood products,
animal wastes, isolation wastes, and used and unused sharps (syringes,
needles, scalpel blades, etc.). Regulated medical waste that has been both
treated, so as to substantially reduce or eliminate its potential for
causing disease, and destroyed, is not regulated once the treatment and
destruction processes have been completed. However, generators who both
treat and destroy regulated medical waste on-site are subject to specified
recordkeeping requirements. Note that hazardous wastes as defined under the
Resource Conservation and Recovery Act (RCRA) in 40 CFR Part 261 are not
covered by the new EPA rule. Therefore, "mixed waste" (waste with both a
RCRA hazardous component and a radioactive component) are not included in
these new requirements. However, mixtures of RCRA hazardous waste and
regulated medical waste may be subject to the tracking requirements in some
circumstances.
20.311 requires that wastes shipped to a
commercial low-level radioactive waste disposal site meet the waste
classification and waste form requirements in 10 CFR Part 61. The low-level
radioactive waste regulations, 10 CFR Part 61, require that hazardous,
biological, pathogenic, or infectious material be treated to reduce to the
maximum extent practical the potential hazard from the non-radiological
materials. Hazardous wastes are covered under the EPA requirements in 40
CFR 260-270. However, radioactive medical wastes having a biological,
pathogenic, or infectious component need to be treated prior to shipment for
disposal. Since treated wastes must also be destroyed in order to be
exempted from the new EPA regulation, we expect some impact on low-level
radioactive waste disposal facility licensees for tracking biological,
pathogenic, and infectious wastes. Licensees in the Covered States
.
IN 89-85
December 15, 1989
Page 3 of 4
who treat and destroy radioactive medical wastes would need to track these
wastes up to the point of treatment and destruction. Because some medical
wastes regulated under the new EPA regulation are only treated, but not
destroyed, and some medical wastes (e.g., unused radioactive material in
syringes) may not require treatment under 10 CFR Part 61, some radioactive
medical wastes would need to be tracked to the disposal site.
The EPA tracking system will provide assurance that regulated medical waste
is properly handled and managed. The regulations require each person in the
chain-of-custody of medical waste management to take responsibility for
assuring that the waste reaches the proper treatment or disposal facility.
A tracking form, described in the new regulation, is required to be used.
The EPA regulation requires generators of regulated medical wastes in the
Covered States to segregate sharps and fluids from other regulated medical
waste and general refuse, to the extent practicable, prior to transport
off-site. The regulation also prescribes packaging in rigid, leak-resistant
containers. Storage of medical wastes must be (a) performed in a manner and
location that maintains the integrity of the packaging and affords
protection from water, rain, and wind, and (b) maintained in a nonputrescent
state. Specific labeling and marking requirements are also set out.
It should be noted that the low-level radioactive waste disposal regulation,
10 CFR Part 61, prohibits the use of cardboard and fiberboard containers.
These requirements were adopted due to several instances where low-level
waste disposal operators injured themselves on needles that penetrated card-
board and fiberboard package containing medical wastes. Since radioactive
medical wastes are generally shipped for disposal in DOT 17H steel drums, no
impact to licensees is expected.
The EPA regulations include a new tracking form for covered medical
materials. In the Federal Register notice it is stated that the EPA
tracking forms would be sufficient for meeting the NRC manifest requirements
under 10 CFR 20.311 for radioactive wastes provided that the additional 10
CFR 20.311 information is included in Box 14 of the form. This statement
needs clarification. Commercial low-level radioactive waste disposal sites
have very different manifest information requirements that could not be
placed on the available space on the EPA form. In addition, Agreement
States regulating commercial low-level radioactive waste disposal sites
require approval of new manifest formats. Consequently, licensees in
Covered States who ship regulated medical waste offsite for treatment or
disposal would need to attach the low-level radioactive waste disposal site
manifest forms to the EPA medical waste tracking forms.
In some cases, generators of regulated medical waste in Covered States may
use waste brokers or processors in non-Covered States. Also, the three
commercial low-level radioactive waste disposal sites are located in
non-Covered States (Nevada, South Carolina, and Washington). The new EPA
regulations apply throughout the country, but only to wastes generated in
Covered States.
.
IN 89-85
December 15, 1989
Page 4 of 4
Therefore, waste brokers, processors, and disposal site operators in
non-Covered States will need to comply with the new EPA medical waste
tracking requirements when they handle, process, or dispose of wastes
generated in Covered States.
This information notice is issued for information only and should not be
construed as a legal interpretation of the EPA regulation. No specification
or written response is required by this information notice. If you have any
questions about this information notice, please contact Timothy C. Johnson
at 301-492-0558 of this office. If you have any questions on the new EPA
regulations, please contact the toll-free RCRA/Superfund Hotline at
800-424-9346 or 202-382-3000 in Washington, DC or Mary Greene, 202-475-8551,
Office of Solid Waste, U.S. Environmental Protection Agency, OS-332, 401 M
Street, S.W., Room S-242, Washington, D.C. 20460. Copies of the new EPA
regulations are available by calling the RCRA/Superfund Hotline.
Richard L. Bangart, Director
Division of Low-Level Waste Management
and Decommissioning
Office of Nuclear Material Safety
and Safeguards
Technical Contact: Timothy C. Johnson, NMSS
301-492-0557
Attachments:
1. List of Recently Issued NMSS Information Notices
2. List of Recently Issued NRC Information Notices
.
Page Last Reviewed/Updated Tuesday, March 09, 2021